A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.

Whether Judge Murphy’s ruling holds through appeal will determine how much institutional credibility can be recovered.

Scientists suggest findings highlight potential targets and could lead to the development of therapies that specifically block the tumor’s ability to spread.

Artis was founded to provide platforms and capabilities that drug developers require to bring next-generation medicines to patients.

Skin wound healing shows a unique cellular function mechanism involving the interaction of several cells, growth factors, and ...

The human brain operates as a network of interconnected modules specialized for tasks that become less specialized as people age—a breakdown associated with memory loss and othe ...

Findings identify genes that may represent possible new targets for a "block and lock" strategy for curing HIV.

Novartis has committed up to $3 billion—two-thirds of that upfront—toward acquiring Pikavation Therapeutics, a subsidiary of Synnovation Therapeutics that specializes in developing PI3Kα inhibitor ...

CytomX Therapeutics shares yo-yoed this past week, surging on positive early clinical data for its colorectal cancer candidate, then retreating on investor questions about the data. Also, Eli Lilly ...

Roche’s AI factories, protein design reasoning model, and healthcare robotics are among GTC announcements for biology.

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a ...

Findings from preclinical studies could point to therapeutic strategies for Huntington’s disease, as well as other neurodegenerative disorders and potentially cancer.